APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Opioid Patch

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-Opioid Patch Market Analysis and Forecast 2026-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchNon-Opioid Patch Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Opioid Patch Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Non-Opioid Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Opioid Patch Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Opioid Patch Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Non-Opioid Patch market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non-Opioid Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-Opioid Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-Opioid Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-Opioid Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Non-Opioid Patch include Teva Pharmaceutical Industries Ltd, Johnson and Johnson, Viatris Inc., Sorrento Therapeutics Inc., Purdue Pharma L.P., NEXGEL Advanced Hydrogel Solutions, Hisamitsu Pharmaceutical Co.,Inc., Grunenthal and Endo International plc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non-Opioid Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-Opioid Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Non-Opioid Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Opioid Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-Opioid Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non-Opioid Patch sales, projected growth trends, production technology, application and end-user industry.

Non-Opioid Patch Segment by Company

Teva Pharmaceutical Industries Ltd

Johnson and Johnson

Viatris Inc.

Sorrento Therapeutics Inc.

Purdue Pharma L.P.

NEXGEL Advanced Hydrogel Solutions

Hisamitsu Pharmaceutical Co.,Inc.

Grunenthal

Endo International plc.

Amneal Pharmaceuticals LLC

Non-Opioid Patch Segment by Type

Prescription Medicines

OTC Medicines

Non-Opioid Patch Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Non-Opioid Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Opioid Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Opioid Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Opioid Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Non-Opioid Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Non-Opioid Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Opioid Patch sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-Opioid Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prescription Medicines Major Manufacturers Table 3. OTC Medicines Major Manufacturers Table 4. Global Non-Opioid Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacies Major Manufacturers Table 6. Drug Stores Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Non-Opioid Patch Industry Trends Table 9. Non-Opioid Patch Industry Drivers Table 10. Non-Opioid Patch Industry Opportunities and Challenges Table 11. Non-Opioid Patch Industry Restraints Table 12. Global Non-Opioid Patch Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Non-Opioid Patch Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Non-Opioid Patch Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Non-Opioid Patch Revenue Market Share by Region (2021-2026) Table 16. Global Non-Opioid Patch Revenue Market Share by Region (2027-2032) Table 17. Global Non-Opioid Patch Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Non-Opioid Patch Sales by Region (2021-2026) & (k units) Table 19. Global Non-Opioid Patch Sales by Region (2027-2032) & (k units) Table 20. Global Non-Opioid Patch Sales Market Share by Region (2021-2026) Table 21. Global Non-Opioid Patch Sales Market Share by Region (2027-2032) Table 22. Global Non-Opioid Patch Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Non-Opioid Patch Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Non-Opioid Patch Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Non-Opioid Patch Sales Market Share by Manufacturers (2021-2026) Table 26. Global Non-Opioid Patch Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Non-Opioid Patch Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Non-Opioid Patch Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Non-Opioid Patch Manufacturers, Product Type & Application Table 30. Global Non-Opioid Patch Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Non-Opioid Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Non-Opioid Patch Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Non-Opioid Patch Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Non-Opioid Patch Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Non-Opioid Patch Revenue Market Share by Type (2021-2026) Table 37. Global Non-Opioid Patch Revenue Market Share by Type (2027-2032) Table 38. Global Non-Opioid Patch Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 40. Global Non-Opioid Patch Sales by Type (2027-2032) & (k units) Table 41. Global Non-Opioid Patch Sales Market Share by Type (2021-2026) Table 42. Global Non-Opioid Patch Sales Market Share by Type (2027-2032) Table 43. Global Non-Opioid Patch Price by Type (2021-2026) & (US$/unit) Table 44. Global Non-Opioid Patch Price by Type (2027-2032) & (US$/unit) Table 45. Global Non-Opioid Patch Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Non-Opioid Patch Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Non-Opioid Patch Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Non-Opioid Patch Revenue Market Share by Application (2021-2026) Table 49. Global Non-Opioid Patch Revenue Market Share by Application (2027-2032) Table 50. Global Non-Opioid Patch Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 52. Global Non-Opioid Patch Sales by Application (2027-2032) & (k units) Table 53. Global Non-Opioid Patch Sales Market Share by Application (2021-2026) Table 54. Global Non-Opioid Patch Sales Market Share by Application (2027-2032) Table 55. Global Non-Opioid Patch Price by Application (2021-2026) & (US$/unit) Table 56. Global Non-Opioid Patch Price by Application (2027-2032) & (US$/unit) Table 57. Teva Pharmaceutical Industries Ltd Company Information Table 58. Teva Pharmaceutical Industries Ltd Business Overview Table 59. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio Table 61. Teva Pharmaceutical Industries Ltd Recent Development Table 62. Johnson and Johnson Company Information Table 63. Johnson and Johnson Business Overview Table 64. Johnson and Johnson Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Johnson and Johnson Non-Opioid Patch Product Portfolio Table 66. Johnson and Johnson Recent Development Table 67. Viatris Inc. Company Information Table 68. Viatris Inc. Business Overview Table 69. Viatris Inc. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Viatris Inc. Non-Opioid Patch Product Portfolio Table 71. Viatris Inc. Recent Development Table 72. Sorrento Therapeutics Inc. Company Information Table 73. Sorrento Therapeutics Inc. Business Overview Table 74. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio Table 76. Sorrento Therapeutics Inc. Recent Development Table 77. Purdue Pharma L.P. Company Information Table 78. Purdue Pharma L.P. Business Overview Table 79. Purdue Pharma L.P. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Purdue Pharma L.P. Non-Opioid Patch Product Portfolio Table 81. Purdue Pharma L.P. Recent Development Table 82. NEXGEL Advanced Hydrogel Solutions Company Information Table 83. NEXGEL Advanced Hydrogel Solutions Business Overview Table 84. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio Table 86. NEXGEL Advanced Hydrogel Solutions Recent Development Table 87. Hisamitsu Pharmaceutical Co.,Inc. Company Information Table 88. Hisamitsu Pharmaceutical Co.,Inc. Business Overview Table 89. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio Table 91. Hisamitsu Pharmaceutical Co.,Inc. Recent Development Table 92. Grunenthal Company Information Table 93. Grunenthal Business Overview Table 94. Grunenthal Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Grunenthal Non-Opioid Patch Product Portfolio Table 96. Grunenthal Recent Development Table 97. Endo International plc. Company Information Table 98. Endo International plc. Business Overview Table 99. Endo International plc. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Endo International plc. Non-Opioid Patch Product Portfolio Table 101. Endo International plc. Recent Development Table 102. Amneal Pharmaceuticals LLC Company Information Table 103. Amneal Pharmaceuticals LLC Business Overview Table 104. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio Table 106. Amneal Pharmaceuticals LLC Recent Development Table 107. North America Non-Opioid Patch Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Non-Opioid Patch Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 110. North America Non-Opioid Patch Sales by Type (2027-2032) & (k units) Table 111. North America Non-Opioid Patch Sales Price by Type (2021-2026) & (US$/unit) Table 112. North America Non-Opioid Patch Sales Price by Type (2027-2032) & (US$/unit) Table 113. North America Non-Opioid Patch Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Non-Opioid Patch Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 116. North America Non-Opioid Patch Sales by Application (2027-2032) & (k units) Table 117. North America Non-Opioid Patch Sales Price by Application (2021-2026) & (US$/unit) Table 118. North America Non-Opioid Patch Sales Price by Application (2027-2032) & (US$/unit) Table 119. North America Non-Opioid Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Non-Opioid Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Non-Opioid Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Non-Opioid Patch Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 123. North America Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 124. North America Non-Opioid Patch Sales by Country (2027-2032) & (k units) Table 125. North America Non-Opioid Patch Sales Price by Country (2021-2026) & (US$/unit) Table 126. North America Non-Opioid Patch Sales Price by Country (2027-2032) & (US$/unit) Table 127. United States Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 128. Canada Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 129. Mexico Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 130. Europe Non-Opioid Patch Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Non-Opioid Patch Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 133. Europe Non-Opioid Patch Sales by Type (2027-2032) & (k units) Table 134. Europe Non-Opioid Patch Sales Price by Type (2021-2026) & (US$/unit) Table 135. Europe Non-Opioid Patch Sales Price by Type (2027-2032) & (US$/unit) Table 136. Europe Non-Opioid Patch Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Non-Opioid Patch Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 139. Europe Non-Opioid Patch Sales by Application (2027-2032) & (k units) Table 140. Europe Non-Opioid Patch Sales Price by Application (2021-2026) & (US$/unit) Table 141. Europe Non-Opioid Patch Sales Price by Application (2027-2032) & (US$/unit) Table 142. Europe Non-Opioid Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Non-Opioid Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Non-Opioid Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Non-Opioid Patch Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 146. Europe Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 147. Europe Non-Opioid Patch Sales by Country (2027-2032) & (k units) Table 148. Europe Non-Opioid Patch Sales Price by Country (2021-2026) & (US$/unit) Table 149. Europe Non-Opioid Patch Sales Price by Country (2027-2032) & (US$/unit) Table 150. Germany Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 151. France Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 152. U.K. Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 153. Italy Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 154. Russia Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 155. Spain Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 156. Netherlands Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 157. Switzerland Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 158. Sweden Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 159. Poland Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 160. China Non-Opioid Patch Revenue by Type (2021-2026) & (US$ Million) Table 161. China Non-Opioid Patch Revenue by Type (2027-2032) & (US$ Million) Table 162. China Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 163. China Non-Opioid Patch Sales by Type (2027-2032) & (k units) Table 164. China Non-Opioid Patch Sales Price by Type (2021-2026) & (US$/unit) Table 165. China Non-Opioid Patch Sales Price by Type (2027-2032) & (US$/unit) Table 166. China Non-Opioid Patch Revenue by Application (2021-2026) & (US$ Million) Table 167. China Non-Opioid Patch Revenue by Application (2027-2032) & (US$ Million) Table 168. China Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 169. China Non-Opioid Patch Sales by Application (2027-2032) & (k units) Table 170. China Non-Opioid Patch Sales Price by Application (2021-2026) & (US$/unit) Table 171. China Non-Opioid Patch Sales Price by Application (2027-2032) & (US$/unit) Table 172. Asia Non-Opioid Patch Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Non-Opioid Patch Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 175. Asia Non-Opioid Patch Sales by Type (2027-2032) & (k units) Table 176. Asia Non-Opioid Patch Sales Price by Type (2021-2026) & (US$/unit) Table 177. Asia Non-Opioid Patch Sales Price by Type (2027-2032) & (US$/unit) Table 178. Asia Non-Opioid Patch Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Non-Opioid Patch Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 181. Asia Non-Opioid Patch Sales by Application (2027-2032) & (k units) Table 182. Asia Non-Opioid Patch Sales Price by Application (2021-2026) & (US$/unit) Table 183. Asia Non-Opioid Patch Sales Price by Application (2027-2032) & (US$/unit) Table 184. Asia Non-Opioid Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Non-Opioid Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Non-Opioid Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Non-Opioid Patch Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. Asia Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 189. Asia Non-Opioid Patch Sales by Country (2027-2032) & (k units) Table 190. Asia Non-Opioid Patch Sales Price by Country (2021-2026) & (US$/unit) Table 191. Asia Non-Opioid Patch Sales Price by Country (2027-2032) & (US$/unit) Table 192. Japan Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 193. South Korea Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 194. India Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 195. Australia Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 196. Taiwan Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Non-Opioid Patch Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Non-Opioid Patch Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 201. SAMEA Non-Opioid Patch Sales by Type (2027-2032) & (k units) Table 202. SAMEA Non-Opioid Patch Sales Price by Type (2021-2026) & (US$/unit) Table 203. SAMEA Non-Opioid Patch Sales Price by Type (2027-2032) & (US$/unit) Table 204. SAMEA Non-Opioid Patch Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Non-Opioid Patch Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 207. SAMEA Non-Opioid Patch Sales by Application (2027-2032) & (k units) Table 208. SAMEA Non-Opioid Patch Sales Price by Application (2021-2026) & (US$/unit) Table 209. SAMEA Non-Opioid Patch Sales Price by Application (2027-2032) & (US$/unit) Table 210. SAMEA Non-Opioid Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Non-Opioid Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Non-Opioid Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Non-Opioid Patch Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 214. SAMEA Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 215. SAMEA Non-Opioid Patch Sales by Country (2027-2032) & (k units) Table 216. SAMEA Non-Opioid Patch Sales Price by Country (2021-2026) & (US$/unit) Table 217. SAMEA Non-Opioid Patch Sales Price by Country (2027-2032) & (US$/unit) Table 218. Brazil Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 219. Argentina Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 220. Chile Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 221. Colombia Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 222. Peru Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 224. Israel Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 225. UAE Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 226. Turkey Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 227. Iran Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 228. Egypt Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Non-Opioid Patch Distributors List Table 232. Non-Opioid Patch Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Non-Opioid Patch Image Figure 2. Global Non-Opioid Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Opioid Patch Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prescription Medicines Image Figure 5. OTC Medicines Image Figure 6. Global Non-Opioid Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Non-Opioid Patch Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacies Image Figure 9. Drug Stores Image Figure 10. Online Pharmacies Image Figure 11. Global Non-Opioid Patch Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Figure 13. Global Non-Opioid Patch Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Non-Opioid Patch Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Non-Opioid Patch Revenue Market Share by Region (2021-2032) Figure 16. Global Non-Opioid Patch Sales (2021-2032) & (k units) Figure 17. Global Non-Opioid Patch Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Non-Opioid Patch Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Non-Opioid Patch Sales YoY (2021-2032) & (k units) Figure 20. Europe Non-Opioid Patch Sales YoY (2021-2032) & (k units) Figure 21. China Non-Opioid Patch Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Non-Opioid Patch Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Non-Opioid Patch Sales YoY (2021-2032) & (k units) Figure 24. Global Non-Opioid Patch Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Non-Opioid Patch Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Non-Opioid Patch Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Non-Opioid Patch Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Non-Opioid Patch Revenue Market Share by Type (2021-2032) Figure 30. Global Non-Opioid Patch Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Non-Opioid Patch Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Non-Opioid Patch Sales Market Share by Type (2021-2032) Figure 33. Global Non-Opioid Patch Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Non-Opioid Patch Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Non-Opioid Patch Revenue Market Share by Application (2021-2032) Figure 36. Global Non-Opioid Patch Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Non-Opioid Patch Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Non-Opioid Patch Sales Market Share by Application (2021-2032) Figure 39. North America Non-Opioid Patch Revenue Share by Type (2021-2032) Figure 40. North America Non-Opioid Patch Sales Share by Type (2021-2032) Figure 41. North America Non-Opioid Patch Revenue Share by Application (2021-2032) Figure 42. North America Non-Opioid Patch Sales Share by Application (2021-2032) Figure 43. North America Non-Opioid Patch Revenue Share by Country (2021-2032) Figure 44. North America Non-Opioid Patch Sales Share by Country (2021-2032) Figure 45. Europe Non-Opioid Patch Revenue Share by Type (2021-2032) Figure 46. Europe Non-Opioid Patch Sales Share by Type (2021-2032) Figure 47. Europe Non-Opioid Patch Revenue Share by Application (2021-2032) Figure 48. Europe Non-Opioid Patch Sales Share by Application (2021-2032) Figure 49. Europe Non-Opioid Patch Revenue Share by Country (2021-2032) Figure 50. Europe Non-Opioid Patch Sales Share by Country (2021-2032) Figure 51. China Non-Opioid Patch Revenue Share by Type (2021-2032) Figure 52. China Non-Opioid Patch Sales Share by Type (2021-2032) Figure 53. China Non-Opioid Patch Revenue Share by Application (2021-2032) Figure 54. China Non-Opioid Patch Sales Share by Application (2021-2032) Figure 55. Asia Non-Opioid Patch Revenue Share by Type (2021-2032) Figure 56. Asia Non-Opioid Patch Sales Share by Type (2021-2032) Figure 57. Asia Non-Opioid Patch Revenue Share by Application (2021-2032) Figure 58. Asia Non-Opioid Patch Sales Share by Application (2021-2032) Figure 59. Asia Non-Opioid Patch Revenue Share by Country (2021-2032) Figure 60. Asia Non-Opioid Patch Sales Share by Country (2021-2032) Figure 61. SAMEA Non-Opioid Patch Revenue Share by Type (2021-2032) Figure 62. SAMEA Non-Opioid Patch Sales Share by Type (2021-2032) Figure 63. SAMEA Non-Opioid Patch Revenue Share by Application (2021-2032) Figure 64. SAMEA Non-Opioid Patch Sales Share by Application (2021-2032) Figure 65. SAMEA Non-Opioid Patch Revenue Share by Country (2021-2032) Figure 66. SAMEA Non-Opioid Patch Sales Share by Country (2021-2032) Figure 67. Non-Opioid Patch Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Non-Opioid Patch Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Medicines
  • OTC Medicines
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Johnson and Johnson
  • Viatris Inc.
  • Sorrento Therapeutics Inc.
  • Purdue Pharma L.P.
  • NEXGEL Advanced Hydrogel Solutions
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Grunenthal
  • Endo International plc.
  • Amneal Pharmaceuticals LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-Opioid Patch Market by Type
  3. 1.2.1 Global Non-Opioid Patch Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prescription Medicines
  5. 1.2.3 OTC Medicines
  6. 1.3 Non-Opioid Patch Market by Application
  7. 1.3.1 Global Non-Opioid Patch Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacies
  9. 1.3.3 Drug Stores
  10. 1.3.4 Online Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Non-Opioid Patch Market Dynamics
  1. 2.1 Non-Opioid Patch Industry Trends
  2. 2.2 Non-Opioid Patch Industry Drivers
  3. 2.3 Non-Opioid Patch Industry Opportunities and Challenges
  4. 2.4 Non-Opioid Patch Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Non-Opioid Patch Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Non-Opioid Patch Revenue by Region
  3. 3.2.1 Global Non-Opioid Patch Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-Opioid Patch Revenue by Region (2021-2026)
  5. 3.2.3 Global Non-Opioid Patch Revenue by Region (2027-2032)
  6. 3.2.4 Global Non-Opioid Patch Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Non-Opioid Patch Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Non-Opioid Patch Sales by Region
  9. 3.4.1 Global Non-Opioid Patch Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Non-Opioid Patch Sales by Region (2021-2026)
  11. 3.4.3 Global Non-Opioid Patch Sales by Region (2027-2032)
  12. 3.4.4 Global Non-Opioid Patch Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Non-Opioid Patch Revenue by Manufacturers
  2. 4.1.1 Global Non-Opioid Patch Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Non-Opioid Patch Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Non-Opioid Patch Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-Opioid Patch Sales by Manufacturers
  6. 4.2.1 Global Non-Opioid Patch Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Non-Opioid Patch Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Non-Opioid Patch Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Non-Opioid Patch Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Non-Opioid Patch Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Non-Opioid Patch Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Non-Opioid Patch Manufacturers, Product Type & Application
  13. 4.7 Global Non-Opioid Patch Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Non-Opioid Patch Market CR5 and HHI
  16. 4.8.2 2025 Non-Opioid Patch Tier 1, Tier 2, and Tier 3
5 Non-Opioid Patch Market by Type
  1. 5.1 Global Non-Opioid Patch Revenue by Type
  2. 5.1.1 Global Non-Opioid Patch Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Non-Opioid Patch Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Non-Opioid Patch Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Non-Opioid Patch Sales by Type
  6. 5.2.1 Global Non-Opioid Patch Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-Opioid Patch Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Non-Opioid Patch Sales Market Share by Type (2021-2032)
  9. 5.3 Global Non-Opioid Patch Price by Type
6 Non-Opioid Patch Market by Application
  1. 6.1 Global Non-Opioid Patch Revenue by Application
  2. 6.1.1 Global Non-Opioid Patch Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Non-Opioid Patch Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Non-Opioid Patch Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Non-Opioid Patch Sales by Application
  6. 6.2.1 Global Non-Opioid Patch Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Non-Opioid Patch Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Non-Opioid Patch Sales Market Share by Application (2021-2032)
  9. 6.3 Global Non-Opioid Patch Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries Ltd
  2. 7.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 7.2 Johnson and Johnson
  8. 7.2.1 Johnson and Johnson Company Information
  9. 7.2.2 Johnson and Johnson Business Overview
  10. 7.2.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson and Johnson Non-Opioid Patch Product Portfolio
  12. 7.2.5 Johnson and Johnson Recent Developments
  13. 7.3 Viatris Inc.
  14. 7.3.1 Viatris Inc. Company Information
  15. 7.3.2 Viatris Inc. Business Overview
  16. 7.3.3 Viatris Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Viatris Inc. Non-Opioid Patch Product Portfolio
  18. 7.3.5 Viatris Inc. Recent Developments
  19. 7.4 Sorrento Therapeutics Inc.
  20. 7.4.1 Sorrento Therapeutics Inc. Company Information
  21. 7.4.2 Sorrento Therapeutics Inc. Business Overview
  22. 7.4.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio
  24. 7.4.5 Sorrento Therapeutics Inc. Recent Developments
  25. 7.5 Purdue Pharma L.P.
  26. 7.5.1 Purdue Pharma L.P. Company Information
  27. 7.5.2 Purdue Pharma L.P. Business Overview
  28. 7.5.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Purdue Pharma L.P. Non-Opioid Patch Product Portfolio
  30. 7.5.5 Purdue Pharma L.P. Recent Developments
  31. 7.6 NEXGEL Advanced Hydrogel Solutions
  32. 7.6.1 NEXGEL Advanced Hydrogel Solutions Company Information
  33. 7.6.2 NEXGEL Advanced Hydrogel Solutions Business Overview
  34. 7.6.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio
  36. 7.6.5 NEXGEL Advanced Hydrogel Solutions Recent Developments
  37. 7.7 Hisamitsu Pharmaceutical Co.,Inc.
  38. 7.7.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
  39. 7.7.2 Hisamitsu Pharmaceutical Co.,Inc. Business Overview
  40. 7.7.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio
  42. 7.7.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments
  43. 7.8 Grunenthal
  44. 7.8.1 Grunenthal Company Information
  45. 7.8.2 Grunenthal Business Overview
  46. 7.8.3 Grunenthal Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Grunenthal Non-Opioid Patch Product Portfolio
  48. 7.8.5 Grunenthal Recent Developments
  49. 7.9 Endo International plc.
  50. 7.9.1 Endo International plc. Company Information
  51. 7.9.2 Endo International plc. Business Overview
  52. 7.9.3 Endo International plc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Endo International plc. Non-Opioid Patch Product Portfolio
  54. 7.9.5 Endo International plc. Recent Developments
  55. 7.10 Amneal Pharmaceuticals LLC
  56. 7.10.1 Amneal Pharmaceuticals LLC Company Information
  57. 7.10.2 Amneal Pharmaceuticals LLC Business Overview
  58. 7.10.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio
  60. 7.10.5 Amneal Pharmaceuticals LLC Recent Developments
8 North America
  1. 8.1 North America Non-Opioid Patch Market Size by Type
  2. 8.1.1 North America Non-Opioid Patch Revenue by Type (2021-2032)
  3. 8.1.2 North America Non-Opioid Patch Sales by Type (2021-2032)
  4. 8.1.3 North America Non-Opioid Patch Price by Type (2021-2032)
  5. 8.2 North America Non-Opioid Patch Market Size by Application
  6. 8.2.1 North America Non-Opioid Patch Revenue by Application (2021-2032)
  7. 8.2.2 North America Non-Opioid Patch Sales by Application (2021-2032)
  8. 8.2.3 North America Non-Opioid Patch Price by Application (2021-2032)
  9. 8.3 North America Non-Opioid Patch Market Size by Country
  10. 8.3.1 North America Non-Opioid Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Non-Opioid Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Non-Opioid Patch Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Non-Opioid Patch Market Size by Type
  2. 9.1.1 Europe Non-Opioid Patch Revenue by Type (2021-2032)
  3. 9.1.2 Europe Non-Opioid Patch Sales by Type (2021-2032)
  4. 9.1.3 Europe Non-Opioid Patch Price by Type (2021-2032)
  5. 9.2 Europe Non-Opioid Patch Market Size by Application
  6. 9.2.1 Europe Non-Opioid Patch Revenue by Application (2021-2032)
  7. 9.2.2 Europe Non-Opioid Patch Sales by Application (2021-2032)
  8. 9.2.3 Europe Non-Opioid Patch Price by Application (2021-2032)
  9. 9.3 Europe Non-Opioid Patch Market Size by Country
  10. 9.3.1 Europe Non-Opioid Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Non-Opioid Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Non-Opioid Patch Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Non-Opioid Patch Market Size by Type
  2. 10.1.1 China Non-Opioid Patch Revenue by Type (2021-2032)
  3. 10.1.2 China Non-Opioid Patch Sales by Type (2021-2032)
  4. 10.1.3 China Non-Opioid Patch Price by Type (2021-2032)
  5. 10.2 China Non-Opioid Patch Market Size by Application
  6. 10.2.1 China Non-Opioid Patch Revenue by Application (2021-2032)
  7. 10.2.2 China Non-Opioid Patch Sales by Application (2021-2032)
  8. 10.2.3 China Non-Opioid Patch Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-Opioid Patch Market Size by Type
  2. 11.1.1 Asia Non-Opioid Patch Revenue by Type (2021-2032)
  3. 11.1.2 Asia Non-Opioid Patch Sales by Type (2021-2032)
  4. 11.1.3 Asia Non-Opioid Patch Price by Type (2021-2032)
  5. 11.2 Asia Non-Opioid Patch Market Size by Application
  6. 11.2.1 Asia Non-Opioid Patch Revenue by Application (2021-2032)
  7. 11.2.2 Asia Non-Opioid Patch Sales by Application (2021-2032)
  8. 11.2.3 Asia Non-Opioid Patch Price by Application (2021-2032)
  9. 11.3 Asia Non-Opioid Patch Market Size by Country
  10. 11.3.1 Asia Non-Opioid Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Non-Opioid Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Non-Opioid Patch Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-Opioid Patch Market Size by Type
  2. 12.1.1 SAMEA Non-Opioid Patch Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Non-Opioid Patch Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Non-Opioid Patch Price by Type (2021-2032)
  5. 12.2 SAMEA Non-Opioid Patch Market Size by Application
  6. 12.2.1 SAMEA Non-Opioid Patch Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Non-Opioid Patch Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Non-Opioid Patch Price by Application (2021-2032)
  9. 12.3 SAMEA Non-Opioid Patch Market Size by Country
  10. 12.3.1 SAMEA Non-Opioid Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Non-Opioid Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Non-Opioid Patch Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Non-Opioid Patch Value Chain Analysis
  2. 13.1.1 Non-Opioid Patch Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Non-Opioid Patch Production Mode & Process
  6. 13.2 Non-Opioid Patch Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Non-Opioid Patch Distributors
  9. 13.2.3 Non-Opioid Patch Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst